These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17483075

  • 1. Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain.
    Nogami K, Shima M, Giddings JC, Takeyama M, Tanaka I, Yoshioka A.
    Int J Hematol; 2007 May; 85(4):317-22. PubMed ID: 17483075
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
    Saenko EL, Shima M, Rajalakshmi KJ, Scandella D.
    J Biol Chem; 1994 Apr 15; 269(15):11601-5. PubMed ID: 7512568
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Common inhibitory effects of human anti-C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor.
    Shima M, Nakai H, Scandella D, Tanaka I, Sawamoto Y, Kamisue S, Morichika S, Murakami T, Yoshioka A.
    Br J Haematol; 1995 Nov 15; 91(3):714-21. PubMed ID: 8555081
    [Abstract] [Full Text] [Related]

  • 6. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M, Scandella D, Yoshioka A, Nakai H, Tanaka I, Kamisue S, Terada S, Fukui H.
    Thromb Haemost; 1993 Mar 01; 69(3):240-6. PubMed ID: 7682339
    [Abstract] [Full Text] [Related]

  • 7. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
    Yada K, Nogami K, Shima M.
    Br J Haematol; 2013 Oct 01; 163(1):104-11. PubMed ID: 23889549
    [Abstract] [Full Text] [Related]

  • 8. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
    Nogami K, Shima M, Nishiya K, Sakurai Y, Tanaka I, Giddings JC, Saenko EL, Yoshioka A.
    Thromb Haemost; 2002 Mar 01; 87(3):459-65. PubMed ID: 11916079
    [Abstract] [Full Text] [Related]

  • 9. Contributions of Asn2198, Met2199, and Phe2200 in the factor VIII C2 domain to cofactor activity, phospholipid-binding, and von Willebrand factor-binding.
    Lewis DA, Pound ML, Ortel TL.
    Thromb Haemost; 2003 May 01; 89(5):795-802. PubMed ID: 12719775
    [Abstract] [Full Text] [Related]

  • 10. Factor VIII inhibitor antibodies with C2 domain specificity are less inhibitory to factor VIII complexed with von Willebrand factor.
    Suzuki T, Arai M, Amano K, Kagawa K, Fukutake K.
    Thromb Haemost; 1996 Nov 01; 76(5):749-54. PubMed ID: 8950785
    [Abstract] [Full Text] [Related]

  • 11. A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF-binding site distant from its epitope.
    Dimitrov JD, Roumenina LT, Plantier JL, Andre S, Saboulard D, Meslier Y, Planchais C, Jacquemin M, Saint-Remy JM, Atanasov BP, Kaveri SV, Lacroix-Desmazes S.
    J Thromb Haemost; 2010 Jul 01; 8(7):1524-31. PubMed ID: 20374449
    [Abstract] [Full Text] [Related]

  • 12. High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors.
    Batsuli G, Deng W, Healey JF, Parker ET, Baldwin WH, Cox C, Nguyen B, Kahle J, Königs C, Li R, Lollar P, Meeks SL.
    Blood; 2016 Oct 20; 128(16):2055-2067. PubMed ID: 27381905
    [Abstract] [Full Text] [Related]

  • 13. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
    Yada K, Nogami K, Takeyama M, Ogiwara K, Wakabayashi H, Shima M.
    J Thromb Haemost; 2015 Oct 20; 13(10):1843-53. PubMed ID: 26278069
    [Abstract] [Full Text] [Related]

  • 14. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor.
    Saenko EL, Scandella D.
    J Biol Chem; 1997 Jul 18; 272(29):18007-14. PubMed ID: 9218428
    [Abstract] [Full Text] [Related]

  • 15. Factor VIII inhibitors: a 50-year perspective.
    Green D.
    Haemophilia; 2011 Nov 18; 17(6):831-8. PubMed ID: 21592257
    [Abstract] [Full Text] [Related]

  • 16. Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site.
    Pratt KP, Qian J, Ellaban E, Okita DK, Diethelm-Okita BM, Conti-Fine B, Scott DW.
    Thromb Haemost; 2004 Sep 18; 92(3):522-8. PubMed ID: 15351848
    [Abstract] [Full Text] [Related]

  • 17. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H, Obert B, Houllier A, Fressinaud E, Rothschild C, Meyer D, Girma JP.
    Thromb Haemost; 2000 Feb 18; 83(2):274-81. PubMed ID: 10739386
    [Abstract] [Full Text] [Related]

  • 18. Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody.
    Lin JC, Ettinger RA, Schuman JT, Zhang AH, Wamiq-Adhami M, Nguyen PC, Nakaya-Fletcher SM, Puranik K, Thompson AR, Pratt KP.
    PLoS One; 2015 Feb 18; 10(1):e0116577. PubMed ID: 25615825
    [Abstract] [Full Text] [Related]

  • 19. Epitope specificity and inactivation mechanisms of factor VIII inhibitor antibodies.
    Scandella D.
    Vox Sang; 1999 Feb 18; 77 Suppl 1():17-20. PubMed ID: 10529680
    [Abstract] [Full Text] [Related]

  • 20. Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development.
    d'Oiron R, Lavergne JM, Lavend'homme R, Benhida A, Bordet JC, Negrier C, Peerlinck K, Vermylen J, Saint-Remy JM, Jacquemin M.
    Blood; 2004 Jan 01; 103(1):155-7. PubMed ID: 12969981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.